⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024

Supplementary Figure 1 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool

Paulien Kaptein Nadine Slingerland Christina Metoikidou Felix Prinz Simone Brokamp Mercedes Machuca-Ostos Guido de Roo Ton N. Schumacher Yik A. Yeung Kelly D. Moynihan Ivana M. Djuretic Daniela S. Thommen

View at Publisher

Ask AI

Bookmark

Share

Abstract

CD8-IL2 activates CD8⁺ T cells in human tumor samples with high specificity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kaptein et al. (2024) studied this question.

synapsesocial.com/papers/68e62195b6db6435875b375a https://doi.org/10.1158/2159-8290.26134333

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024
2Supplementary Figure 10 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024
3Supplementary Figure 10 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024
4Supplementary Figure 8 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024
5Supplementary Figure 8 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024

More related papers

Supplementary Figure 6 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024
Supplementary Figure 6 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024
Supplementary Figure 3 from CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool2024